The ABP Pediatric Hematology-Oncology certification covers eleven distinct domains, ranging from erythrocytes and leukocytes to solid tumors and stem-cell transplants. The American Board of Pediatrics oversees this current credential, which features a duration of 270 minutes and a passing score of 180 for candidates seeking subspecialty recognition in this medical field.
Pediatricians pursuing subspecialty certification in pediatric hematology-oncology will take this exam. Candidates demonstrate proficiency across bone marrow failure, hemostasis, transfusion medicine, and hematologic malignancies during the evaluation process.
Review all eleven domains outlined by the American Board of Pediatrics carefully before test day. Focus heavily on solid tumors, general oncology, and erythrocytes, which carry the largest domain weights on the 270-minute exam to help you achieve the passing score of 180 successfully during your final testing attempt.
This domain focuses intensely on erythrocytes, covering red blood cell production, destruction, and related disorders. Candidates review clinical presentations and diagnostic criteria for various pediatric anemias within this category.
This section covers leukocytes and white blood cell disorders encountered frequently in pediatric populations. Candidates study normal leukocyte development alongside pathological conditions affecting white blood cells during clinical practice.
This domain examines platelets and associated disorders affecting pediatric patients. Review covers normal platelet function, production rates, and quantitative or qualitative platelet abnormalities requiring medical attention and diagnostic evaluation.
This specific section addresses hemostasis and thrombosis in pediatric hematology practice. Candidates examine specific coagulation pathways, bleeding disorders, and thrombotic events requiring clinical intervention and ongoing patient management strategies.
This domain covers bone marrow failure syndromes occurring in children. Study topics include congenital and acquired conditions affecting bone marrow production, cellular output, and related hematologic parameters during clinical assessments.
This extensive section examines transfusion medicine practices relevant to pediatric patient care. Topics include blood product administration, transfusion reactions, and component therapy management protocols used extensively in hospital settings during treatments.
This domain focuses on general oncology issues encountered in pediatric patients. Candidates review supportive care principles, late effects of treatment protocols, and acute oncologic emergencies requiring rapid medical responses.
This section covers hematologic malignancies such as leukemia and lymphoma. Review includes disease pathophysiology, classification systems, and modern treatment protocols designed specifically for pediatric patients undergoing targeted therapy programs.
This domain addresses solid tumors occurring frequently in pediatric populations. Candidates study diagnosis methods, clinical staging procedures, and therapeutic approaches for various childhood solid neoplasms and related cancers.
This vital section focuses on hematopoietic stem-cell transplantation procedures for children. Review includes crucial conditioning regimens, strict donor selection criteria, and the thorough management of transplant-related complications in pediatric hematology-oncology patients.
This domain covers core knowledge in scholarly activities for pediatric hematology-oncology specialists. Candidates examine research methods, study design principles, and data interpretation techniques relevant to clinical investigation in this field.
Manage your time effectively across the full 270-minute duration. Pace yourself carefully to answer all questions across the 11 domains without rushing through the material.
The passing score for the ABP Pediatric Hematology-Oncology exam is 180. Candidates must meet or exceed this exact score to achieve certification from the American Board of Pediatrics.
The examination has a total duration of 270 minutes, giving test-takers ample time to complete all questions across the eleven evaluation domains during their scheduled appointment.
The certification exam covers 11 distinct domains, including erythrocytes, solid tumors, and hematopoietic stem-cell transplantation, distributed across the entire testing framework for a complete and thorough assessment of candidates.
Yes, this page details the current certification exam. For long-term certification path questions, check directly with the American Board of Pediatrics to confirm all policies.
Verified 2026-09-13
This overview was built using the official exam guide provided by the American Board of Pediatrics, detailing domains, weights, and scoring criteria.